Security record · archived quarter
BCRX
BioCryst Pharmaceuticals, Inc. · Healthcare · Biotechnology
18Tracked holders
+1Δ holders
80.75MShares held
$723.56MReported value
+1New positions
−0Exits
Momentum inputs (comparable managers):
holder breadth +5.9% ·
share flow +17.0% ·
net new positions +5.6%
— formula
Broad accumulation — rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2025
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 109 | +4 | 139.04M | $1.39B | +8 | −4 |
| Q1 2026 | 108 | +4 | 130.67M | $1.24B | +14 | −10 |
| Q4 2025 | 103 | -1 | 127.11M | $991.41M | — | −1 |
| Q3 2025 | 22 | +2 | 89.66M | $680.51M | +2 | −1 |
| Q2 2025 | 18 | +1 | 80.75M | $723.56M | +1 | — |
| Q1 2025 | 14 | +1 | 26.41M | $198.06M | +1 | — |
| Q4 2024 | 13 | -2 | 21.17M | $159.22M | — | −2 |
| Q3 2024 | 14 | +4 | 16.62M | $126.32M | +4 | — |
| Q2 2024 | 10 | — | 15.77M | $97.44M | — | — |
Who holds it · Q2 2025
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passive) | 21.43M | — | $191.98M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | BlackRock ✦ (passive) | 21.43M | — | $191.98M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (passive) | 21.43M | — | $191.98M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (passive) | 21.43M | — | $191.98M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (passive) | 21.43M | — | $191.98M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (passive) | 21.43M | — | $191.98M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (passive) | 21.43M | — | $191.98M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (passive) | 21.43M | — | $191.98M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (passive) | 21.43M | — | $191.98M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (passive) | 21.43M | — | $191.98M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (passive) | 21.43M | — | $191.98M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (passive) | 21.43M | — | $191.98M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (passive) | 21.43M | — | $191.98M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (passive) | 21.43M | — | $191.98M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | BlackRock ✦ (passive) | 21.43M | — | $191.98M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | BlackRock ✦ (passive) | 21.43M | — | $191.98M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | BlackRock ✦ (passive) | 21.43M | — | $191.98M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | The Vanguard Group ✦ (passive) | 20.54M | — | $184.08M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | The Vanguard Group ✦ (passive) | 20.54M | — | $184.08M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | The Vanguard Group ✦ (passive) | 20.54M | — | $184.08M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | The Vanguard Group ✦ (passive) | 20.54M | — | $184.08M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | The Vanguard Group ✦ (passive) | 20.54M | — | $184.08M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | State Street Global Advisors ✦ (passive) | 8.51M | +8.9% | $76.21M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 24 | Geode Capital Management ✦ (passive) | 5.05M | +1.9% | $45.30M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 25 | Geode Capital Management ✦ (passive) | 5.05M | +1.9% | $45.30M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 26 | D. E. Shaw & Co. ✦ | 4.39M | +176.2% | $39.33M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 27 | D. E. Shaw & Co. ✦ | 4.39M | +176.2% | $39.33M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 28 | Two Sigma Investments ✦ | 4.29M | +109.6% | $38.42M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 29 | Arrowstreet Capital ✦ | 4.28M | +2103.7% | $38.34M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 30 | Fisher Asset Management ✦ | 2.78M | -8.8% | $24.93M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 31 | Citadel Advisors ✦ | 2.56M | +345.4% | $22.91M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 32 | Citadel Advisors ✦ | 2.56M | +345.4% | $22.91M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 33 | Renaissance Technologies ✦ | 2.53M | +317.5% | $22.64M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 34 | Millennium Management ✦ | 1.91M | -50.0% | $17.08M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 35 | AQR Capital Management ✦ | 1.15M | -4.4% | $10.29M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 36 | AQR Capital Management ✦ | 1.15M | -4.4% | $10.29M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 37 | AQR Capital Management ✦ | 1.15M | -4.4% | $10.29M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 38 | AQR Capital Management ✦ | 1.15M | -4.4% | $10.29M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 39 | AQR Capital Management ✦ | 1.15M | -4.4% | $10.29M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 40 | Fidelity (FMR) ✦ | 655.89K | — | $5.88M | 0.0% | n/c | 1 | SEC ↗ |
| 41 | Fidelity (FMR) ✦ | 655.89K | — | $5.88M | 0.0% | n/c | 1 | SEC ↗ |
| 42 | Fidelity (FMR) ✦ | 655.89K | — | $5.88M | 0.0% | n/c | 1 | SEC ↗ |
| 43 | Gotham Asset Management ✦ | 201.81K | +358.0% | $1.81M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 44 | T. Rowe Price ✦ | 146.64K | +9.2% | $1.31M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 45 | Marshall Wace ✦ | 143.31K | New | $1.28M | 0.0% | New | 1 | SEC ↗ |
| 46 | Marshall Wace ✦ | 143.31K | New | $1.28M | 0.0% | New | 1 | SEC ↗ |
| 47 | Norges Bank ✦ (passive) | 111.15K | -61.4% | $995,922 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 48 | Wellington Management ✦ | 86.78K | -5.0% | $777,531 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 49 | Wellington Management ✦ | 86.78K | -5.0% | $777,531 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 50 | Wellington Management ✦ | 86.78K | -5.0% | $777,531 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 51 | Wellington Management ✦ | 86.78K | -5.0% | $777,531 | 0.0% | ▼ Trim | 4 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Marshall Wace | $1.28M | 0.0% |
| Marshall Wace | $1.28M | 0.0% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 298 holders, 245.96M shares, $2.30B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q2 2025 ·
Methodology ·
Get this via the API